Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver

U.S. Trade Representative Katherine Tai on Monday met virtually with top executives of drugmakers Pfizer (PFE.N) and AstraZeneca PLC (AZN.L) to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic.